Top Markets
Coin of the day
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Rankning i aktier #20226
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Aktiekurs
$1.91
Marknadsvärde
$136.47M
Förändring (1 dag)
-1.15%
Förändring (1 år)
21.17%
Land
TW
Handel Sinew Pharma Inc. (6634)

Kategori

Historik för aktiesplit för Sinew Pharma Inc. (6634)
Aktien Sinew Pharma Inc. (symbol: 6634) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 24, 2026.
En 6634-aktie köpt före Aug 24, 2026 motsvarar nu 0 6634-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH